Apellis Pharmaceuticals Inc Sobi Strategic Collaboration Conference Call Transcript
Thank you, everyone, and welcome to the Apellis Pharmaceuticals conference call to discuss their collaboration with Sobi. Today's call is being recorded. At this time, I'd like to turn the call over to Tracy Vineis, Vice President of Communications at Apellis.
Good morning, and thank you for joining us to discuss Apellis' strategic collaboration with Sobi for systemic pegcetacoplan. For those participating by conference call, slides are available via webcast at apellis.com.
Before we begin, I would like to point out that we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.
On today's call, I am joined by Co-Founder and Chief Executive Officer, Dr. Cedric Francois, who will discuss our new collaboration with Sobi. Joining us
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |